The experiments outlined in this proposal are aimed at the development of murine models for the investigation of mechanisms involved in the immunopathologic phenomena associated with certain poorly understood ocular inflammatory diseases, including uveitis, scleritis, and Sjogren's syndrome. In order to elucidate the immunopathogenetic mechanisms involved, a series of investigations are proposed utilizing inbred autoimmune strains of mice, primarily the MRL/Mp strain. The MRL/Mp mouse is prone to autoimmune disease and exists in two substrains, the MRL/Mp-+/+ and the MRL/Mp-lpr/lpr mouse. The lpr gene is a single autosomal mutation which induces massive lymphoproliferation of T cells and markedly accelerates the course of the autoimmune disease. Both substrains develop lacrimal gland inflammation, and aged MRL/Mp-lpr/lrp mice develop choroiditis and scleritis. Studies in this animal system will: 1) characterize the temporal evolution of the inflammatory infiltrate; 2) characterize immunohistologically the mononuclear cell infiltrate in the target ocular tissues, utilizing monoclonal antibodies to cell surface antigens; and 3) investigate the mechanisms by which tissue destruction occurs in the target ocular tissues. Attempts will also be made to directly induce site-specific ocular lesions within these mice utilizing 1) the type II collagen arthritis model for production of murine scleritis and 2) induction of experimental allergic uveoretinitis (EAU) by immunization with retinal S antigen. A further phase of these investigations will be directed toward alteration of naturally occurring or induced immunopathology by treatment of the MRL/Mp mouse with the immunomodulating agent cyclosporine.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY005912-03
Application #
3261604
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1986-08-01
Project End
1990-07-31
Budget Start
1988-08-01
Budget End
1989-07-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Jabs, Douglas A; Prendergast, Robert A; Campbell, Adam L et al. (2007) Autoimmune Th2-mediated dacryoadenitis in MRL/MpJ mice becomes Th1-mediated in IL-4 deficient MRL/MpJ mice. Invest Ophthalmol Vis Sci 48:5624-9
Jabs, D A; Kuppers, R C; Saboori, A M et al. (1994) Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice. Cell Immunol 154:66-76
Jabs, D A; Prendergast, R A (1994) Murine models of Sjogren's syndrome. Adv Exp Med Biol 350:623-30
Jabs, D A; Burek, C L; Hu, Q et al. (1992) Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol 141:496-507
Jabs, D A; Prendergast, R A (1991) Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody. Invest Ophthalmol Vis Sci 32:2718-22
Jabs, D A; Enger, C; Prendergast, R A (1991) Murine models of Sjogren's syndrome. Evolution of the lacrimal gland inflammatory lesions. Invest Ophthalmol Vis Sci 32:371-80
Jabs, D A; Prendergast, R A (1991) Ocular inflammation in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci 32:1944-7
Jabs, D A; Prendergast, R A (1988) Murine models of Sjogren's syndrome. Immunohistologic analysis of different strains. Invest Ophthalmol Vis Sci 29:1437-43
Jabs, D A; Prendergast, R A (1987) Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4. J Exp Med 166:1198-203